NOTICES: AIDS, STD and TB Laboratory Research Division,
Published: 2000-11-28
Part C (Centers for Disease Control and Prevention) of the
Statement of Organizations, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 6777276, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 65 FR 68144, dated November 14, 2000) is
amended to
NOTICES: Proposed collection; comment request,
Published: 2000-11-28
Proposed Projects
Title: Child Care CaseLevel Report.
OMB No.: 09700167.
Description: Section 658K of the Child Care and Development Block
Grant Act of 1990 (Pub. L. 101508, 42 U.S.C. 9858) requires that
States and Territories submit monthly caselevel data on the children
and families receiving direct services under the Child Care and
RULES: Salinomycin, bacitracin methylene disalicylate,
Published: 2000-11-28
The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a new animal drug application
(NADA) filed by Alpharma, Inc. The NADA provides for use of approved,
singleingredient salinomycin and bacitracin methylene disalicylate
Type A medicated articles to make twoway combination drug Type C
RULES: Paper and paperboard components—; 4-(diiodomethylsulfonyl) toluene,
Published: 2000-11-28
The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of 4
(diiodomethylsulfonyl) toluene as a slimicide in the manufacture of
foodcontact paper and paperboard. This action is in response to a
petition filed by Angus Chemical Co.
NOTICES: Proposed collection; comment request,
Published: 2000-11-28
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each
NOTICES: Submission for OMB review; comment request,
Published: 2000-11-28
The Food and Drug Administration (FDA) is announcing that the
proposed collection of information listed below has been submitted to
the Office of Management and Budget (OMB) for review and clearance
under the Paperwork Reduction Act of 1995.
NOTICES: Asahi Chemical Industry Co., Ltd., et al.; withdrawn,
Published: 2000-11-28
The Food and Drug Administration (FDA) is announcing the
withdrawal, without prejudice to a future filing, of 18 food additive
petitions proposing that the food additive regulations be amended to
provide for the safe use of certain new food additives. The petitioners
subsequently requested that their petitions be converted to food
contact
NOTICES: 2001 National Antimicrobial Resistance Monitoring System Scientific Meeting,
Published: 2000-11-28
The Food and Drug Administration (FDA) is announcing the
following meeting entitled ``2001 NARMS Scientific Meeting.'' The topic
to be discussed is the results from NARMS and related antimicrobial
resistance research.
NOTICES: Food safety risk analysis clearinghouse; data quality issues,
Published: 2000-11-28
The Food and Drug Administration (FDA) is announcing a public
meeting cosponsored by the interagency Risk Assessment Consortium (RAC)
and the Joint Institute for Food Safety and Applied Nutrition (JIFSAN).
The purpose of this public meeting is to encourage discussion and gain
input from the public and professionals on data quality issues as they
PROPOSED RULES: See Centers for Disease Control and Prevention; See Children and Families Administration; See Food and Drug Administration; See Health Care Financing Administration; See Health Resources and Services Administration; See National Institutes of Health; Protection of research misconduct whistleblowers; Public Health Service standards,
Published: 2000-11-28
The Department proposes to add a new Subchapter I, Part 94, to
Title 42 of the Code of Federal Regulations to implement section 493(e)
of the Public Health Service Act. Under this proposed regulation,
covered institutions must follow certain requirements for preventing or
otherwise responding to occurrences of retaliation against
whistleblowers.
NOTICES: Complementary and Alternative Medicine Policy, White House Commission,
Published: 2000-11-28
Pursuant to Section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is given of a meeting of the
White House Commission on Complementary and Alternative Medicine Policy.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
NOTICES: Dreyer, Evan B., M.D., Ph.D.,
Published: 2000-11-28
Notice is hereby given that the Office of Research Integrity
(ORI) and the Assistant Secretary for Health have taken final action in the following case:
Evan B. Dreyer, M.D., Ph.D., Massachusetts Eye and Ear Infirmary
(MEEI) and Harvard Medical School (HMS): Based on the findings and
evidence documented in a report by a joint inquiry panel,
NOTICES: Training in Primary Care Medicine and Dentistry Advisory Committee,
Published: 2000-11-28
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92463), announcement is made of the
following National Advisory body scheduled to meet during the month of December 2000.
Name: Advisory Committee on Training in Primary Care Medicine and Dentistry.
Date and Time: December 7, 2000, 8 a.m.5 p.m.;
NOTICES: Advisory Committee to the Director,
Published: 2000-11-28
Pursuant to Pub. Law 92463, notice is hereby given of a meeting of the Advisory Committee to the Director, NIH.
The entire meeting will be open to the public as indicated
below,with attendance limited to space available. Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable
NOTICES: National Cancer Institute,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board.
The meeting will open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such
NOTICES: National Cancer Institute,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Cancer Institute,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Cancer Institute,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Cancer Institute,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions
NOTICES: National Center for Research Resources,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Eye Institute,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Allergy and Infectious Diseases,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of
the National Advisory Allergy and Infectious Diseases Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and
NOTICES: National Institute of Arthritis and Musculoskeletal and Skin Diseases,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIAMS.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the
NOTICES: National Institute of Diabetes and Digestive and Kidney Diseases,
Published: 2000-11-28
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C. as amended. The grant applications and the